$4.17+0.03 (+0.72%)
EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally.
EDAP TMS S.A. in the Healthcare sector is trading at $4.17. The stock is currently 17% below its 52-week high of $5.05, remaining 40.9% above its 200-day moving average. Technical signals show overbought RSI of 74 and bullish MACD crossover, explaining why EDAP maintains its current momentum and trend strength. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The ...
Edap Tms (NASDAQ:EDAP) reported what management described as a “strong first quarter” for 2026, highlighted by record first-quarter revenue and continued momentum in its high-intensity focused ultrasound (HIFU) business centered on the company’s Focal One robotic platform. Record quarterly revenue
European equities traded in the US as American depositary receipts were tracking lower late Thursday
European equities traded in the US as American depositary receipts were higher late Tuesday morning,
European equities traded in the US as American depositary receipts kicked off the week lower late Mo
European equities traded in the US as American depositary receipts were lower late Wednesday morning